Your browser doesn't support javascript.
loading
Therapeutic effect of osimertinib plus cranial radiotherapy compared to osimertinib alone in NSCLC patients with EGFR-activating mutations and brain metastases: a retrospective study.
Zhai, Xiaoyang; Li, Wanhu; Li, Ji; Jia, Wenxiao; Jing, Wang; Tian, Yaru; Xu, Shuhui; Li, Yuying; Zhu, Hui; Yu, Jinming.
Afiliação
  • Zhai X; Shantou University Medical College, Shantou, 515041, Guangdong Province, China.
  • Li W; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, 250117, Shandong Province, China.
  • Li J; Department of Radiology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, Shandong Province, China.
  • Jia W; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, 250117, Shandong Province, China.
  • Jing W; Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, China.
  • Tian Y; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, 250117, Shandong Province, China.
  • Xu S; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, 250117, Shandong Province, China.
  • Li Y; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, 250117, Shandong Province, China.
  • Zhu H; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, 250117, Shandong Province, China.
  • Yu J; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, 250117, Shandong Province, China.
Radiat Oncol ; 16(1): 233, 2021 Dec 05.
Article em En | MEDLINE | ID: mdl-34865626
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Mortalidade / Geral / Tipos_de_cancer / Pulmao / Tratamento / Radioterapia Base de dados: MEDLINE Assunto principal: Acrilamidas / Neoplasias Encefálicas / Irradiação Craniana / Carcinoma Pulmonar de Células não Pequenas / Quimiorradioterapia / Compostos de Anilina / Mutação Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Radiat Oncol Assunto da revista: NEOPLASIAS / RADIOTERAPIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Mortalidade / Geral / Tipos_de_cancer / Pulmao / Tratamento / Radioterapia Base de dados: MEDLINE Assunto principal: Acrilamidas / Neoplasias Encefálicas / Irradiação Craniana / Carcinoma Pulmonar de Células não Pequenas / Quimiorradioterapia / Compostos de Anilina / Mutação Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Radiat Oncol Assunto da revista: NEOPLASIAS / RADIOTERAPIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China